The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.

The Nigeria Customs Service (NCS) has announced the implementation of a presidential executive order granting a two-year exemption ...

HOPE Therapeutics, wholly owned by NRx Pharmaceuticals (NRXP), announced signing of a binding Letter of Intent, LOI, to acquire a majority ...

U.S. stocks looked set to rise again on Monday, with investors hopeful President Donald Trump’s “Liberation Day” tariffs ...